ERIS Lifesciences Ltd.

BSE: 532540 NSE: ERIS Lifesciences ISIN:  INE467B01029 SECTOR: IT Software Company Company’s Website: IPO Date & Price: July 29, 2004 | Rs.

ERIS Lifesciences Overview:

Stock Symbol in NSEStock Symbol in BSECurrent PriceMarket Cap. (Cr)P/E RatioCurrent EPS

ERIS Lifesciences

Its the Indian No-1 multinational information service and consulting Provider company. ERIS Lifesciences is the Subsidiary Company of TATA Group and it’s founded in 1968.

ERIS Lifesciences Sector Performance and Peer Comparison with Sector Analysis:

Did You Know?

<Space for Feature Image>

  • ERIS Lifesciences is the
  • Its Belong to Group.

Balance Sheets & Profit & Loss Account:

YearMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2020Mar 2019

ERIS Lifesciences Share Price Forecast Based on Current Growth +5/-5:

Share Price and EPS Forecast Based on Current Average Growth Rates:

Next 5 Years (CG)Next 10 Years (CG)Next 20 Years (CG)

Share Price and EPS Forecast Based on Current Average Growth Rates Plus 5%:

Next 5 Years (CG+5%)Next 10 Years (CG+5%)Next 20 Years (CG+5%)

Share Price and EPS Forecast Based on Current Average Growth Rates Minus 5%:

Next 5 Years (CG-5%)Next 10 Years (CG-5%)Next 20 Years (CG-5%)

ERIS Lifesciences Quarterly Result, Date & Street Estimate:

Share NameQuarter ResultsYearStreet EstimatesProfitsGrowth

Fundamental Analysis of ERIS Lifesciences :

ERIS Lifesciences Share Long Term Investment Price Target:

Long Term Investment TagetsPriceQnt.Ratio

ERIS Lifesciences Fundamentals SWAT Analysis by AMT

 Strengths, Weaknesses, Opportunities, and Threats of ERIS Lifesciences


  • Strengths Analysis will coming Soon.


  • Weakness Analysis will coming Soon.


  • Opportunity Analysis will coming Soon.


  • Threats Analysis will coming Soon.

Where we can See ERIS Lifesciences in Next 5 Year, 10 Year & 20 Year?

Technical Analysis of ERIS Lifesciences :

ERIS Lifesciences Share Weekly Swing Trading Price Target:

Demand And Supply ZoneSupport LevelsSupport PriceResistance LevelsResistance Price

ERIS Lifesciences Share Today Intraday Price Target:

IntradayTarget Today [Short Selling]IntradayTarget Today [Long Buying]

FAQ on ERIS Lifesciences :

Is it Good to Buy ERIS Lifesciences Share?

Yes, ERIS Lifesciences is India Number-1 IT Software company, with lots business potential in next few year. Its Fundamentally strong Stock we recommend to buy at around 20-25 PE Ration price target. Anyway This company is quite famous for Good Dividends.

Is ERIS Lifesciences Debt Free Company?

ERIS Lifesciences is a Debt free company. Its can easily survived any down turn for 5-10 Quarter business growth.

Is ERIS Lifesciences Overvalued?

Currently ERIS Lifesciences is Trading at P/E Ratio which is

Is ERIS Lifesciences Better than Infosys?

Both and working as a

Why ERIS Lifesciences Share Price is Falling?

Do to Covid-19 pandemic ERIS Lifesciences Share drastically fall.

Why ERIS Lifesciences Share Price is Going Up?

Is ERIS Lifesciences Good for Long Term Investment?

Its depend on when you and at what price you have buy this share, ERIS Lifesciences at 20-25 P/E Ration is a excellent buy call for long Term Investment.

ERIS Lifesciences ‘s Products/Projects:


IPO, Split, Bonus, Dividend Buyback History:

ERIS Lifesciences First IPO was initiate on July 29, 2004. equity shares were put on sale during the IPO with a price band of Rs -Rs per equity share.

[ninja_tables id=”79734″

Company Profile:

CEO NameAmit Bakshi
CFO NameMr.Sachin Shah
CEO SalaryN/A
Company AddressPlot No. 30 & 31, Brahmaputra Industrial Park, Under Mouza-Sila Senduri Ghopa, Amingaon, North Guwahati, Guwahati, Assam 781031
Contact Number079-30451111 (Corporate Office)
Email Address[email protected]

Declaration: Investing in the Stock market is full of Risky. AllMoneyTips.COM doesn’t give any guarantee or warranted on its investment advice. Do your research before investing in the stock market. Our Forecast and buying selling levels of stocks is based on price action and demand and supply zone. There is no guarantee come with our prediction. Take it as advice only. We are not responsible for your losses on your investments.